๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of pharmacological data for bioavailability and pharmacokinetic analyses

โœ Scribed by Paul A. Kramer


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
486 KB
Volume
66
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A comparison of population and standard
โœ Dale K. Yu; Sam J. Hutcheson; Greg Wei; Vijay O. Bhargava; Scott J. Weir ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 576 KB

Vigabatrin (VGB), an irreversible inhibitor of GABA, is being developed as an add-on therapy for uncontrolled complex partial seizure. A single-dose study was conducted in three groups of subjects with normal, mild-to-moderate, and moderate-to-severe renal impairment to examine the effect of renal f

Improved pharmacokinetic and bioavailabi
โœ Sean X. Peng; Beth A. Rockafellow; Tina M. Skedzielewski; Norman D. Huebert; Wil ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB ๐Ÿ‘ 1 views

Pharmacokinetic studies in mice traditionally require one animal per time point, resulting in dosing and euthanizing a large number of animals and producing suboptimal quality of pharmacokinetic data due to inter-animal variability and dosing error. These studies are time-consuming and labor-intensi

Methodology for using oral dose pharmaco
โœ Mingxing Zhou; Robert E. Notari ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 615 KB

A computer aided method for selecting drugs as potential candidates for oral prolonged release formulations has been previously published. In order to decide whether trial formulations were warranted, prolonged release dosing was simulated to find all release rates and doses producing successful reg